Factors Related Analysis to Premature Withdrawal of Antiviral Therapy in Chronic Hepatitis C Patients Treated With Pegylated Interferon α-2b Plus Ribavirin

碩士 === 經國管理暨健康學院 === 健康產業管理研究所 === 102 === Aims:The major recent advance in CHC treatment has been the invention of combination therapy with pegylated IFN plus ribavirin. Despite the efficacy, it is sometimes accompanied by side effects that may lead to compromised medical adherence and early termin...

Full description

Bibliographic Details
Main Authors: Pen-Yuan Liu, 劉本雲
Other Authors: Ting-Chung Huang
Format: Others
Language:zh-TW
Published: 2014
Online Access:http://ndltd.ncl.edu.tw/handle/03463707487538307825